Friday, January 27, 2012

Chevron profit falls as refineries, output suffer (Reuters)

(Reuters) ? Chevron Corp reported lower quarterly earnings on Friday, missing Wall Street forecasts, as rising spending on oil and gas projects and losses at its U.S. refinery business offset gains from higher crude oil prices.

Oil and gas output at the No. 2 U.S. oil company also declined to 2.64 million barrels per day (BPD) from 2.79 million BPD a year-ago, although benchmark oil prices rose about 25 percent during the quarter.

Chevron had said earlier this month its refinery margins were suffering and would be near breakeven for the quarter, but the U.S. losses pulled the entire segment into the red, and the company's profits from oil and gas sales also appeared weaker than expected.

Its shares fell 2.5 percent in early trading.

"It was a miss on some non-controllable factors," said Pavel Molchanov, analyst with Raymond James in Houston, citing the timings of sales and global pricing differences as the likely reason oil and gas profits fell about $500 million below his forecast.

Still, Chevron added 1.67 billion barrels of oil equivalent to its reserves last year, 171 percent of its 2011 output, a very strong performance, Molchanov said.

Chevron is embroiled in two major legal battles in South America, where a Brazilian prosecutor plans to file criminal charges against it and some of its local managers.

The company is facing an $11 billion lawsuit there related to an offshore oil spill in November, and it also remains locked in a legal war against plaintiffs in Ecuador, who won an $18 billion judgment against it in a court there.

PROFIT DIP

Fourth-quarter profit slipped to $5.1 billion, or $2.58 per share, from $5.3 billion, or $2.64 per share, a year earlier.

That fell short of the $2.84 per share that analysts had forecast, according to Thomson Reuters I/B/E/S.

Chevron's warning of weaker earnings on January 11 knocked 17 cents per share off the average analyst estimate.

Among other U.S. oil companies, the quarterly profits from ConocoPhillips and Occidental Petroleum Corp earlier this week topped Wall Street estimates, though Hess Corp fell short.

Exxon Mobil is due to report earnings on Tuesday, Jan 31.

Chevron is spending piles of money on production growth that will not really kick in until 2014. Its 2012 capital budget of $32.7 billion is nearly $5 billion higher than last year.

In the fourth quarter, Chevron's spending on oil and gas projects in the United States nearly doubled from a year ago to $2.0 billion, while outside the U.S. it grew by more than a quarter to $5.1 billion.

Shares of Chevron fell 2.5 percent to $103.94 in early trading on the New York Stock Exchange.

(Reporting by Matt Daily in New York, additional reporting by Braden Reddall in San Francisco, editing by Dave Zimmerman)

Source: http://us.rd.yahoo.com/dailynews/rss/energy/*http%3A//news.yahoo.com/s/nm/20120127/bs_nm/us_chevron

the hub pat robertson evan rachel wood i don t know how she does it katamari roatan bobby fischer

Thursday, January 26, 2012

Poachers threaten rare wild-growing venus flytrap

(AP) ? The venus flytrap's struggle for survival in the wild along coast of the Carolinas faces an added threat from poachers looking to make a buck by uprooting and selling them.

North Carolina wildlife enforcement officer Matt Criscoe says three people were arrested this week and charged with uprooting an endangered species without permission, a misdemeanor. Criscoe says they took about 200 plants, which they expected to sell for about 10 cents apiece.

A spokeswoman for the nonprofit group The Nature Conservancy says that roadside stands sell the plants for about $15 each.

The species grows wild only in the sandy soils within about 100 miles of the coast of North Carolina and South Carolina.

Associated Press

Source: http://hosted2.ap.org/APDEFAULT/b2f0ca3a594644ee9e50a8ec4ce2d6de/Article_2012-01-25-Venus%20Flytrap%20Arrests/id-9d12410efce647c0b57f1a489b94b172

newt gingrich wife callista rick perry travis barker get back on board marianne gingrich rob lowe peyton manning

Discovery identifies potential target for anti-craving medications

Wednesday, January 25, 2012

Scientists at the Centre for Addiction and Mental Health (CAMH) have identified a potential target for the development of anti-craving medications for people with addictions to stimulants such as methamphetamine.

The discovery centres on a brain receptor related to the chemical dopamine, which has a complex role in addictive behaviours.

Using brain scans and a novel chemical probe developed in CAMH's Research Imaging Centre, CAMH scientists found that the probe had high levels of binding to the dopamine D3 receptor in some people with methamphetamine addiction, compared with those who had no addiction. Higher levels of D3 were also linked to participants' reported motivation to take drugs.

"This is the first time, to our knowledge, that anyone has shown that D3 receptor levels are high in people with an active addiction to methamphetamine," says Dr. Isabelle Boileau, a scientist in the Research Imaging Centre, part of the new Campbell Family Research Institute at CAMH. Boileau led the study that appears in the January 25, 2012 issue of The Journal of Neuroscience.

Using positron emission tomography (PET), Boileau's team looked at D3 levels in 16 people who were dependent on methamphetamine. Participants abstained from methamphetamine use for 14 days prior to brain scans. Their results were compared with scans from 16 participants with no addiction. On a separate day after scanning, participants were given a low dose of amphetamine, and they had to report how much they wanted to use drugs.

D3 receptors appear to have a role in craving, but it is not fully established how they are related to drug-related behaviours. The new chemical probe developed at CAMH, called 11C-(+)-PHNO, binds to dopamine D3 receptors. This probe allows researchers to study D3 in people for the first time, using PET scans, in order to answer questions about its role in stimulant addiction.

Understanding the role of brain receptors in addiction has enabled researchers to develop treatment medications, such as nicotine replacement therapy for smoking. So far, therapeutic strategies for stimulant addiction have focused on increasing activity with D2 receptors, where binding levels have been low.

"We can now suggest that any therapeutic approach aimed at increasing activity with D2 receptors should consider being selective at targeting D2, and not increasing D3 levels," says Boileau. "Our finding also supports the idea that D3 should be considered another target for anti-craving medications."

Boileau is also looking at the role of D3 in different types of addictions, including cocaine and gambling.

Building on CAMH?s record of innovation and discovery, the Campbell Family Mental Health Research Institute will be accelerating discoveries in the areas of mood disorders, addictions, schizophrenia and cognitive impairment.

CAMH?s Research Imaging Centre is the first of its kind in Canada where positron emission tomography (PET), magnetic resonance imaging (MRI), and imaging-genetics are dedicated to the study of mental illness and addictions.

This new discovery is an example of the innovative brain science at CAMH's new Research Imaging Centre, the first of its kind in Canada where positron emission tomography (PET), magnetic resonance imaging (MRI), and genetic imaging are dedicated to the study of mental illness and addictions.

###

Centre for Addiction and Mental Health: http://www.camh.net

Thanks to Centre for Addiction and Mental Health for this article.

This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.

This press release has been viewed 49 time(s).

Source: http://www.labspaces.net/117047/Discovery_identifies_potential_target_for_anti_craving_medications_

tragedy of the commons casey jones casey jones debit card fees debit card fees how to be a gentleman how to be a gentleman

Wednesday, January 25, 2012

Studies: Avastin may fight early breast cancers (AP)

Surprising results from two new studies may reopen debate about the value of Avastin for breast cancer. The drug helped make tumors disappear in certain women with early-stage disease, researchers found.

Avastin recently lost approval for treating advanced breast cancer, but the new studies suggest it might help women whose disease has not spread so widely. These were the first big tests of the drug for early breast cancer, and doctors were cautiously excited that it showed potential to help.

In one study, just over one third of women given Avastin plus chemotherapy for a few months before surgery had no sign of cancer in their breasts when doctors went to operate, versus 28 percent of women given chemo alone. In the other study, more than 18 percent on Avastin plus chemo had no cancer in their breasts or lymph nodes at surgery versus 15 percent of those on chemo alone.

A big caveat, though: The true test is whether Avastin improves survival, and it's too soon to know that ? both studies are still tracking the women's health. The drug also has serious side effects.

"I don't think it's clear yet whether this is going to be a winner," Dr. Harry Bear of Virginia Commonwealth University said of Avastin. But he added, "I don't think we're done with it."

Bear led one study, in the United States. Dr. Gunter von Minckwitz of the University of Frankfurt led the other in Germany. Results are in Thursday's New England Journal of Medicine.

Avastin (uh-VAS'-tihn) is still on the market for some colon, lung, kidney and brain tumors. In 2008, it won conditional U.S. approval for advanced breast cancer because it seemed to slow the disease. Further research showed it didn't meaningfully extend life and could cause heart problems, bleeding and other problems. The government revoked its approval for breast cancer in November.

Now doctors can prescribe Avastin for breast cancer but insurers may not pay. Treatment can cost $10,000 a month. The drug is made by California-based Genentech, part of the Swiss company Roche. It is still approved for treating advanced breast cancer in Europe and Japan.

The new studies tested it in a relatively novel way ? before surgery. This is sometimes done to shrink tumors that seem inoperable, or to enable women to have just a lump removed instead of the whole breast.

The women in the studies had tumors that were large enough to warrant treatment besides surgery. Their cancers were not the type that can be treated by Herceptin, another widely used drug.

In the U.S. study, 1,200 women were given chemo or chemo plus infusions of Avastin. By the time of their surgery, no cancer could be found in the breasts of more than 34 percent of those given Avastin versus 28 percent of the others. (Surgeons still have to operate because they don't know the tumor is gone until they check tissue samples.)

The German study involved 1,900 women including some with larger tumors. It used a stricter definition of cancer-free at surgery: no sign of disease in the breast or lymph nodes rather than just the breast. No cancer was seen in 18 percent of women on Avastin versus 15 percent of those given only chemo. Different chemo drugs were used ? a factor that might change Avastin's effectiveness.

The U.S. study was paid for by the National Cancer Institute with some support from drug companies. The German study was sponsored by drug companies. Some researchers consult for Genentech or other makers of cancer drugs.

If even one of these studies shows a survival advantage for Avastin "that would be a game changer" although side effects remain a concern, said Dr. Gary Lyman. He is a Duke University researcher who was on the federal advisory panel that recommended revoking Avastin's approval.

However, von Minckwitz said side effects are more justifiable in early breast cancer patients because "the intention is cure" rather than in late-stage disease where cure isn't usually possible.

Of the more than 200,000 women in the U.S. diagnosed each year with breast cancer, about 30,000 are like those in the new studies, Lyman estimated.

But the studies' impact could be far greater: The participants' tissue samples are being analyzed for genes and biomarkers to predict which women are most likely to respond to Avastin. That could lead to a relook of using the drug for certain women with advanced disease, too.

Three other studies are under way testing Avastin in early breast cancer; one is expected to have results by the end of this year, said Dr. Sandra Horning, global development chief of cancer drugs for Roche and Genentech. The company does not plan to seek any change in Avastin's use until more results are available, she said.

___

Online:

Studies: http://www.nejm.org

Avastin: http://www.avastin.com

___

Marilynn Marchione can be followed at http://twitter.com/MMarchioneAP

Source: http://us.rd.yahoo.com/dailynews/rss/cancer/*http%3A//news.yahoo.com/s/ap/20120125/ap_on_he_me/us_med_breast_cancer_avastin

thurston moore the island the island mcdonalds beating dreamcatcher georgia tech big east expansion

Egypt's Islamist-led parliament opens first session (Reuters)

CAIRO (Reuters) ? Egypt's parliament opened on Monday for the first time since a historic free election put Islamists in the driving seat after years of repression under deposed President Hosni Mubarak.

The Muslim Brotherhood's Freedom and Justice Party (FJP) was the biggest winner in the first free vote in decades. It has vowed to guide Egypt in the transition to civilian rule after generals took charge following the popular uprising that began on January 25 and ended with Mubarak's ouster on February 11.

"I invite the distinguished assembly to stand and read the fatiha (Muslim prayer) in memory of the martyrs of the January 25 revolution ... because the blood of the martyrs is what brought this day," said Mahmoud al-Saqa, 81, a member of the liberal Wafd party, who as oldest member of the house acted as speaker.

After commemorating with the silent prayer, each member read the oath of office. Some wore bright yellow sashes in protest against military trials of civilians.

One Islamist member, Mamdouh Ismail, read the oath that vows allegiance to the nation and its laws but added his own words "so long as it does not oppose God's law," prompting the speaker to tell him repeat it without his own addition.

The rise of the Islamists marks a sea change from Mubarak's era when parliament was a compliant body stuffed with members of his National Democratic Party, which put loyalty and self-interest before religion or ideology.

The Brotherhood was officially banned but won some seats by running "independent" candidates.

Generals will remain in charge until after a presidential election in June when they have promised to hand over power, though many Egyptians suspect the army may seek to retain influence behind the scenes even after that.

"Today we resume the revolution. We have wasted a year. We have work to do," Kamal Abu Etta, prominent labor union activist and member of the non-religious Karama party, said as he entered the building that was surrounded by police.

One of the first steps in Monday's session of the lower house will be to elect a speaker, set to be the FJP's nominee, Mohamed Saad el-Katatni. Elections to parliament's upper house will be in February.

Although Islamists dominate, it is unclear whether they will form a single bloc in parliament, which will have a key role in drafting the new constitution by picking the 100-strong assembly that will draw up the new document. The Brotherhood has said it wants to be inclusive and ensure all voices in Egypt are heard.

"We will cooperate with everyone: with the political forces inside and outside parliament, with the interim government and with the military council until we reach safety heralded by presidential election," said Essam el-Erian, deputy FJP head.

REVIVAL

Youth movements, who put national pride before religion when they galvanized Egyptians in the 18-day revolt against Mubarak, staged a small demonstration outside to ensure protesters killed in the uprising were not forgotten.

"We do not contest the popular mandate of parliament, but it better deliver on the rights of martyrs and wounded. We fear political parties may vie for political gain and ignore the youth," activist Mohamed Fahmy said before the session began.

Liberals were pushed into third place behind the FJP and ultraconservative Islamist Salafis led by the al-Nour party, the surprise runners up. The FJP says it controls almost half the 498 elected seats, with a few re-runs still to be held.

Monday's session marks the revival of an assembly that in the early 20th century was a vibrant forum for the nation's aspirations and filled with deputies who vied with the monarch and Egypt's British overlords.

Parliament's independent voice was extinguished after a 1952 coup that toppled the king and swept military-backed autocrats to power. Mubarak was a former air force commander and the ruling military council is now led by Mubarak's defense minister for 20 years, Mohamed Hussein Tantawi.

"The Egyptian military seems at this point determined to carve out an exception to democratic rule for its area of power and interest," Human Rights Watch's executive director Kenneth Roth said on Sunday at the launch of the group's annual report in Cairo. [ID:nL2E8CM2QM]

Parliamentarians see the new assembly as bringing Egypt a step closer to ending military rule.

"We say that we respect and appreciate the army but the military council must be held accountable for any mistakes ... No one is above accountability," the Brotherhood's general guide, Mohamed Badie, said last week.

But the Islamist group has also previously said it does not seek a confrontation with the military.

Some analysts have suggested the army will not fully abandon politics unless the Brotherhood and other prominent political parties offer guarantees that it will not face legal retribution over the killing of protesters.

Mubarak, 83, is now on trial for his role in the deaths of 850 people during the uprising. Scores of people have been killed in sporadic violence since then, including demonstrations against army rule in November and December.

(Additional reporting by Tamim Elyan; writing by Edmund Blair; editing by Philippa Fletcher)

Source: http://us.rd.yahoo.com/dailynews/rss/africa/*http%3A//news.yahoo.com/s/nm/20120123/wl_nm/us_egypt_parliament

rogue trader rogue trader gone in 60 seconds gone in 60 seconds our lady of sorrows january jones top gun

Tuesday, January 24, 2012

Warrant needed for GPS tracking, high court says (AP)

WASHINGTON ? In a rare defeat for law enforcement, the Supreme Court unanimously agreed on Monday to bar police from installing GPS technology to track suspects without first getting a judge's approval. The justices made clear it wouldn't be their final word on increasingly advanced high-tech surveillance of Americans.

Indicating they will be monitoring the growing use of such technology, five justices said they could see constitutional and privacy problems with police using many kinds of electronic surveillance for long-term tracking of citizens' movements without warrants.

While the justices differed on legal rationales, their unanimous outcome was an unusual setback for government and police agencies grown accustomed to being given leeway in investigations in post-Sept. 11 America, including by the Supreme Court. The views of at least the five justices raised the possibility of new hurdles down the road for police who want to use high-tech surveillance of suspects, including various types of GPS technology.

"The Supreme Court's decision is an important one because it sends a message that technological advances cannot outpace the American Constitution," said Donald Tibbs, a professor at the Earle Mack School of Law at Drexel University. "The people will retain certain rights even when technology changes how the police are able to conduct their investigations."

A GPS device installed by police on Washington, D.C., nightclub owner Antoine Jones' Jeep and tracked for four weeks helped link him to a suburban house used to stash money and drugs. He was sentenced to life in prison before an appeals court overturned his conviction.

It's not clear how much difficulty police agencies would have with warrant requirements in this area; historically they are rarely denied warrants they request. But the Obama administration argued that getting one could be cumbersome, perhaps impossible in the early stages of an investigation. In the Jones case, police got a warrant but did not install the GPS device until after the warrant had expired and then in a jurisdiction that wasn't covered by the document.

Justice Antonin Scalia said the government's installation of the device, and its use of the GPS to monitor the vehicle's movements, constituted a search, meaning a warrant was required. "Officers encroached on a protected area," Scalia wrote.

Relying on a centuries-old legal principle, he concluded that the police action without a warrant was a trespass and therefore an illegal search. He was joined in his opinion by Chief Justice John Roberts and Justices Anthony Kennedy, Clarence Thomas and Sonia Sotomayor.

All nine justices agreed that the GPS monitoring on the Jeep violated the Fourth Amendment's protection against unreasonable search and seizure, a decision the American Civil Liberties Union said was an "important victory for privacy."

But there was a major division between Scalia, the court's conservative leader, and Justice Samuel Alito, a former federal prosecutor and usually a Scalia ally, over how much further the court should go beyond just saying that police can't put a GPS device on something used by a suspect without a warrant.

Alito wrote, in a concurring opinion, that the trespass was not as important as the suspect's expectation of privacy and the duration of the surveillance.

"The use of longer-term GPS monitoring in investigations of most offenses impinges on expectations of privacy," Alito wrote in an opinion joined by Justices Ruth Bader Ginsburg, Stephen Breyer and Elena Kagan. Sotomayor in her concurring opinion specifically said she agreed with Alito on this conclusion.

No justice embraced the government's argument that the surveillance of Jones was acceptable because he had no expectation of privacy for the Jeep's location on public roads.

Alito added, "We need not identify with precision the point at which the tracking of this vehicle became a search, for the line was surely crossed before the four-week mark."

Regarding the issue of duration, Scalia wrote that "we may have to grapple" with those issues in the future, "but there is no reason for rushing forward to resolve them here."

Sotomayor, in her separate opinion, wrote that it may be time to rethink all police use of tracking technology, not just long-term GPS.

"GPS monitoring generates a precise, comprehensive record of a person's public movement that reflects a wealth of detail about her familial, political, religious and sexual associations," Sotomayor said. "The government can store such records and efficiently mine them for information for years to come."

Alito also said the court and Congress should address how expectations of privacy affect whether warrants are required for remote surveillance using electronic methods that do not require the police to install equipment, such as GPS tracking of mobile telephones. Alito noted, for example, that more than 322 million cellphones have installed equipment that allows wireless carriers to track the phones' locations.

"If long-term monitoring can be accomplished without committing a technical trespass ? suppose for example, that the federal government required or persuaded auto manufacturers to include a GPS tracking device in every car ? the court's theory would provide no protection," Alito said.

Sotomayor agreed. "It may be necessary to reconsider the premise that an individual has no reasonable expectation of privacy in information voluntarily disclosed to their parties," she said.

Washington lawyer Andy Pincus called the decision "a landmark ruling in applying the Fourth Amendment's protections to advances in surveillance technology." Pincus has argued 22 cases before the Supreme Court and filed a brief in the current case on behalf of the Center for Democracy and Technology, a civil liberties group with expertise in law, technology and policy.

Senate Judiciary Committee Chairman Patrick Leahy, D-Vt., said the court's decision was "a victory for privacy rights and for civil liberties in the digital age." He said the ruling highlighted many new privacy threats posed by new technologies. Leahy has introduced legislation to update the Electronic Communications Privacy Act, a 1986 law that specifies standards for government monitoring of cellphone conversations and Internet communications.

The lower appellate court that threw out Jones' conviction also objected to the duration of the surveillance.

The case is U.S. v. Jones, 10-1259.

Source: http://us.rd.yahoo.com/dailynews/rss/topstories/*http%3A//news.yahoo.com/s/ap/20120124/ap_on_hi_te/us_supreme_court_gps_tracking

rose bowl 2012 nfl playoff picture nfl playoff picture ryan seacrest sat cheating scandal the secret life of bees kyle orton

Monday, January 23, 2012

Spokesman: Paterno in serious condition

FILE - In this Nov. 7, 2009, file photo, Penn State Coach Joe Paterno stands with his players before taking the field for an NCAA college football game against Ohio State in State College, Pa. A family spokesman says the former Penn State coach, who is battling lung cancer, is in serious condition after experiencing health complications. The 85-year-old Paterno has been in the hospital since Jan. 13 for observation for what his family had called minor complications from cancer treatments. (AP Photo/Carolyn Kaster, File)

FILE - In this Nov. 7, 2009, file photo, Penn State Coach Joe Paterno stands with his players before taking the field for an NCAA college football game against Ohio State in State College, Pa. A family spokesman says the former Penn State coach, who is battling lung cancer, is in serious condition after experiencing health complications. The 85-year-old Paterno has been in the hospital since Jan. 13 for observation for what his family had called minor complications from cancer treatments. (AP Photo/Carolyn Kaster, File)

FILE - In this Oct. 13, 2007, file photo, Penn State head coach Joe Paterno stands with his team before they take the field to play for an NCAA college football game against Wisconsin in State College, Pa. A family spokesman says the former Penn State coach, who is battling lung cancer, is in serious condition after experiencing health complications. The 85-year-old Paterno has been in the hospital since Jan. 13 for observation for what his family had called minor complications from cancer treatments. (AP Photo/Carolyn Kaster, File)

(AP) ? Former Penn State coach Joe Paterno is in serious condition after experiencing health complications from lung cancer.

"Over the last few days Joe Paterno has experienced further health complications," family spokesman Dan McGinn said in a brief statement Saturday to The Associated Press. "His doctors have now characterized his status as serious.

"His family will have no comment on the situation and asks that their privacy be respected during this difficult time," he said.

The 85-year-old Paterno has been in the hospital since Jan. 13 for observation for what his family had called minor complications from cancer treatments.

Paterno was diagnosed with cancer in November, days after getting ousted as head coach in the aftermath of the child sex abuse charges against former assistant Jerry Sandusky.

This was Paterno's second time in the hospital in a month. He's also recovering from a broken pelvis that required a weeklong stay to make it easier for cancer treatments. Paterno first hurt his pelvis in August when he was accidentally bowled over by a player in preseason practice.

The injury forced the Hall of Famer to spend most of the season coaching from the press box ? until trustees dismissed him Nov. 9, four days after Sandusky was first charged.

Sandusky is out on bail and awaiting trial after denying the allegations. Paterno testified before a state grand jury investigating Sandusky, and authorities have said he is not a target of the probe.

But school trustees voted unanimously to oust him anyway ? even though Paterno had announced that morning he would retire by the end of the season ? in part because Paterno failed a moral responsibility to report an allegation made in 2002 against Sandusky to authorities outside the university.

Paterno testified he had relayed the allegation told to him by graduate assistant Mike McQueary to a superior, and the information was then passed on to another school administrator who oversaw the campus police department.

Paterno's lawyer, Wick Sollers, on Thursday called the board's comments self-serving and unsupported by the facts. Paterno fully reported what he knew to the people responsible for campus investigations, Sollers said.

"He did what he thought was right with the information he had at the time," Sollers said.

Associated Press

Source: http://hosted2.ap.org/APDEFAULT/3d281c11a96b4ad082fe88aa0db04305/Article_2012-01-21-Penn%20State-Paterno/id-ed6a2776385047329f3e4a5bb3de1d06

kc chiefs kc chiefs judy garland duggars j r martinez j r martinez long island serial killer